Together, these data demonstrate that Rb1 effectively attenuates renal dysfunction, tubular injury, and inflammation in IRI-induced AKI, highlighting its potential as a ferroptosis-targeted therapeutic agent. This evidence concerns the gene RB1 and acute kidney injury.